Current
US Lawsuits Against Big Pharma
|
|
Pharmaceutical Industry ‘Business With Disease’ Facing Further Legal
Challenges
A Judge in the Superior Court of New Jersey in the United States, presiding
over a class action lawsuit against the pharmaceutical industry, has
approved a master class action complaint form that can be used by all
plaintiffs who wish to sue the pharma-cartel.
>> Click here to download a copy
in PDF format.
|
| |
US healthcare fraud convictions
up 22%
The number of criminal convictions for healthcare
fraud by companies and individuals rose 22 per cent in the US last
year amid a crackdown by federal authorities
>> More
|
| |
Bristol-Myers Says It Has
Been Subpoenaed
The Bristol-Myers Squibb Company said yesterday
that it had received a subpoena from the United States attorney in
Boston over pricing and marketing of drugs covered by Medicare and
Medicaid.
>> More
|
| |
Pfizer Next In Line
A West Virginia court has ruled that a lawsuit
involving Rezulin, a diabetes drug, can proceed as a class action against
the world's largest drugmaker, Pfizer, Inc.
>> More
|
| |
AstraZeneca and Medco Charged
With Fraud
Crime no longer pays quite as well as it
did--or at least, not for health-care firms involved in cheating the
American government. On June 20th, AstraZeneca, a British drug firm,
agreed to pay $355m to settle federal charges that, among other things,
it gave free samples of its cancer drug, Zoladex, to American doctors,
to curry favour, knowing that these same doctors were billing the government's
Medicare health insurance scheme for unwarranted reimbursement.
>> More
|
| |
Schering-Plough Corporation
Facing Federal Charges Over Illegal Drug Marketing Practices
The Schering-Plough Corporation said yesterday
(May 30th) that it could soon be indicted in a federal investigation
into its prescription drug marketing practices and face charges that
employees destroyed documents related to the case. According to the
company, prosecutors are examining whether Schering-Plough illegally
gave financial grants and other items of value to doctors and other
customers, whether it marketed drugs for unapproved uses and whether
it submitted false pricing information to the government so that Medicaid
paid too much for its products. >> More
|
| |
Trial Lawyers Are Now Focusing
on Lawsuits Against Drug Makers
Enriched and emboldened by the consistent
exposure of their business model by this Foundation and after successful
fights against asbestos and tobacco companies, some of theUSA's top
plaintiffs' lawyers have trained their sights on drug makers, claiming
that many giant pharmaceutical companies have hidden the dangers of
medicines the lawyers say have harmed thousands of people. >> More
|
| |
New York State vs GlaxoSmithKline
and Pharmacia
On February 13th 2003, exactly eleven days
after the publication of Dr Rath's first Open Letter exposing the financial
interests behind the pharmaceutical 'business with disease' New York
State Attorney General Eliot Spitzer filed complaints in the Supreme
Court of the State of New York against GlaxoSmithKline (GSK) and Pharmacia
(now part of Pfizer) for making fraudulent and deceptive misrepresentations
that conceal the true average wholesale price of its drugs from consumers,
Government agencies and drug price reporting services. >> More
|
